Alantra advised the recommended Cash Offer for Cyprotex by Evotec AG for £41.7 million
SECTORHealthcare
ServiceM&A
Value £41.7 million
Related Transactions
-
Sep 2023Sell-side advisorySep 2023SECTOR HealthcareService M&A
-
Jul 2023Sell-side advisoryJul 2023SECTOR HealthcareService M&A
-
Jun 2023Sell-side advisoryJun 2023SECTOR Healthcare; Consumer Goods & RetailService M&A
-
Apr 2023Acquisition FinancingApr 2023SECTOR HealthcareService Acquisition Financing